Clinical Trial Update: Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™) [Phase 2]

View source ↗

Summary

Phase 2 trial of CyCol, an oral colonic-release ciclosporin, for mild to moderate ulcerative colitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CyCol (cyclosporin)

Snippet

Sponsor: Sigmoid Pharma | Conditions: Mild to Moderate Ulcerative Colitis | Phase 2 | Status: COMPLETED